Biomea Fusion, Inc. ('Biomea,” 'Biomea Fusion,” or the 'Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that Juan Pablo Frías, MD, delivered an oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results